En Es
Categories

DIASORIN

DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tests are designed for hospital and private testing laboratories in the markets of immunodiagnostics and molecular diagnostics.
Products Covid-19NewsSummary
Close

Covid-19 DIASORIN

Clinical Laboratory

SARS-CoV-2 Ag Assay
LIAISON SARS-CoV-2 Ag

The LIAISON SARS-CoV-2 Ag assay is a chemiluminescence sandwich-immunoassay (CLIA) based technology for the quantitative determination of Nucleocapsid antigen protein from SARS-CoV-2 samples - in nasal swab (NS), nasopharyngeal swab (NPS) eluted in UTM/VTM directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 10 days of the onset of symptoms. The assay is a unique quantitative solution to detect suspected COVID-19 patients, do contact tracing and rapidly implement isolation procedures for those patients who have been infected and might be able to spread SARS-CoV-2.
More details

SARS-CoV-2 IgM Assay
LIAISON SARS-CoV-2 IgM

The LIAISON SARS-CoV-2 IgM is a fully automated assay to be run on LIAISON X for detecting IgM antibody to the SARS-CoV-2 virus that causes COVID-19. The assay offers high sensitivity and specificity to ensure accurate results along the infection window.
More details

SARS-CoV-2 TrimericS IgG Assay
LIAISON SARS-CoV-2 TrimericS IgG Assay

The LIAISON SARS-CoV-2 TrimericS IgG Assay is a new generation of chemiluminescence immunoassay (CLIA), for the quantitative determination of anti-trimeric spike protein specific IgG antibodies to SARS-CoV-2 in human serum or plasma samples. The assay is intended as an aid in the diagnosis of CoVID-19 and to support the study of the immune status of infected patients by providing an indication of the presence of neutralizing IgG antibodies against SARS-CoV-2.
More details

SARS-CoV-2 S1/S2 IgG Assay
LIAISON SARS-CoV-2 S1/S2 IgG

The LIAISON SARS-CoV-2 S1/S2 IgG is a quantitative assay for the detection of IgG antibodies against S1/S2 antigens of SARS-CoV-2. The fully automated solution with a throughput of up to 170 results/hour on LIAISON XL has high sensitivity and specificity to ensure accurate results. The quantitative assay with correlation to neutralizing antibodies can be used as an upstream pre-screening tool.
More details
Close

News of DIASORIN

DiaSorin to Acquire Siemens' ELISA Immunodiagnostics Business

01 Aug 2017
DiaSorin to Acquire Siemens' ELISA Immunodiagnostics Business
DiaSorin S.p.A. has entered into an agreement to acquire Siemens Healthineers’ micro-titre-based ELISA immunodiagnostic business portfolio and related tangible and intangible assets, including customer sales and distribution contracts, installed base of instruments and relevant intellectual property.
Read More
Close

About DIASORIN

DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tests are designed for hospital and private testing laboratories in the markets of immunodiagnostics and molecular diagnostics.
FaceBook Twitter Google+ Linked in
SARS-CoV-2 S1/S2 IgG Assay

SARS-CoV-2 S1/S2 IgG Assay

Model: LIAISON SARS-CoV-2 S1/S2 IgG
Request Information

Description:

The LIAISON SARS-CoV-2 S1/S2 IgG is a quantitative assay for the detection of IgG antibodies against S1/S2 antigens of SARS-CoV-2. The fully automated solution with a throughput of up to 170 results/hour on LIAISON XL has high sensitivity and specificity to ensure accurate results.
Read More

Full Description Features

Description

The LIAISON SARS-CoV-2 S1/S2 IgG is a quantitative assay for the detection of IgG antibodies against S1/S2 antigens of SARS-CoV-2. The fully automated solution with a throughput of up to 170 results/hour on LIAISON XL has high sensitivity and specificity to ensure accurate results. The quantitative assay with correlation to neutralizing antibodies can be used as an upstream pre-screening tool. Request Information

Features

• KIT FORMAT: 110 tests/integral
• TIME TO FIRST RESULT: 35 minutes
• THROUGHPUT: Up to 170 tests/hour
• OPEN/ON BOARD KIT STABILITY: Up to 4 weeks
• CALIBRATION STABILITY: Up to 4 weeks
• No potential cross-reactivity with other coronaviruses observed: Samples tested - 2 Anti-Human CoV OC43; 1 Anti-Human CoV NL63, 1 Anti-Human CoV 229E, 1 Anti-Human MERS-COV
• No Biotin potential inference observed: Up to 3500 ng/mL Request Information

Send A Message To This Supplier

* Required Information
* Email
To
DIASORIN (SARS-CoV-2 S1/S2 IgG Assay)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions